维百奥生物代理NIBSC品牌全系列产品

维百奥生物代理NIBSC品牌全系列产品

---

英国国家生物制品检定所（NIBSC）是全球生物制品标准化与质量控制的权威公立机构，隶属于英国卫生安全局。其核心使命是为世界卫生组织（WHO）制定、储存和分发国际生物标准品，确保疫苗、血液制品、基因治疗等关键医疗产品的有效性、安全性与质量一致性。作为WHO的全球合作中心，NIBSC的产品线覆盖疫苗、血液制品、治疗性生物药、诊断试剂及先进疗法，尤其在突发公共卫生事件（如流感、COVID-19）中，快速研发并提供关键标准品，支撑全球诊断、治疗和监管体系。

 

▍NIBSC产品线

NIBSC的产品以国际标准品和参考试剂为核心，覆盖以下领域：

● 疫苗相关标准品

⒈病毒疫苗：流感（季节性及大流行株）、脊髓灰质炎、麻疹、风疹、乙肝等疫苗的效价和抗原含量标准品。

⒉细菌疫苗：白喉/破伤风/百日咳（DTP）疫苗、脑膜炎球菌疫苗、肺炎球菌疫苗的标准品。

⒊COVID-19相关：SARS-CoV-2病毒RNA标准品、抗体标准品（用于血清学检测标准化）、疫苗效力评估标准品。

● 血液制品与凝血因子

⒈凝血因子：血友病治疗用的凝血因子Ⅷ、Ⅸ、von Willebrand因子等的活性标准品。

⒉血浆衍生物：免疫球蛋白、抗凝血酶、纤维蛋白原等的国际标准品。

⒊输血安全：HIV、乙肝、丙肝等血液传播病原体的检测标准品。

● 治疗性生物制品

⒈单克隆抗体：如英夫利昔单抗（infliximab）、阿达木单抗（adalimumab）的生物活性标准品。

⒉细胞与基因治疗产品：用于干细胞、CAR-T细胞治疗等的质量控制参考品。

⒊生长激素与细胞因子：如促红细胞生成素（EPO）、干扰素、白细胞介素的标准品。

● 诊断与检测标准品

⒈传染病诊断：HIV、HPV、寨卡病毒、结核病等病原体的核酸或抗体检测标准品。

⒉自身免疫与过敏：抗核抗体、过敏原（如花粉、尘螨）的参考试剂。

● 新兴领域产品

⒈基因编辑技术：CRISPR/Cas9活性标准品。

⒉生物类似药：为生物类似药提供比对参考原研药的标准品。

     

▍NIBSC部分产品列表

 

Product Code	Blood
19/114	Anti-Human Neutrophil Antibody 3a WHO Reference Reagent
18/248	Von Willebrand Factor Concentrate (WHO 3rd International Standard)
21/266	1st International Standard 2022 Anti-β2GPI IgG 200 IU/Vial
Product Code	Infectious diseases
18/180	2nd International Standard for Diphtheria Antitoxin Equine
Dim9	Diphtheria toxoid monoclonal antibody, clone Dim9
DT05	Diphtheria toxoid monoclonal antibody, clone DT05
Product Code	Emerging viruses
21/112	First WHO International Standard for LASV RNA
22/108	Reference Panel for Lassa virus RNA
21/110	Working Reagent for Lassa virus RNA
22/218	Working Reagent for anti-monkeypox virus antibodies
Product Code	Influenza
22/222	Influenza Antigen A/Sydney/175/2022 (IVR-235) (H1N1)
22/220	Influenza Antigen A/Sydney/5/2021 (SAN-013) (H1N1)
22/100	Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1)
	Influenza Antiserum
22/224	Influenza anti-A/Sydney/5/2021-like (H1N1) HA serum
	Influenza Virus
22/146	Influenza Virus Infectious A/Brisbane/02/2018 (H1N1)
22/178	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130
22/144	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014
22/180	Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206
22/138	Influenza Virus Infectious A/Indiana/02/2020 (H1N1)
22/172	Influenza Virus Infectious A/Lyon/820/2021 (H1N1) NIB-132
22/140	Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012
22/158	Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377
22/136	Influenza Virus Infectious A/North Carolina/01/2021 (H1N1)  X-375
22/156	Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X373A
22/200	Influenza Virus Infectious A/Sydney/5/2021 (H1N1)
22/142	Influenza Virus Infectious A/Sydney/5/2021 (H1N1) SAN-013
22/174	Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) NYMC X-379
22/204	Influenza Virus Infectious B/Austria/1359417/2021 (B-Victoria lineage) BVR-26
22/154	Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage)
21/388	Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage)
22/134	Influenza Virus Infectious BX-107A (B-Victoria Lineage)
22/214	Influenza Virus Infectious CBER-48A (A/Sydney/5/2021) (H1N1)
22/234	Influenza Virus Infectious IVR-235 (A/Sydney/175/2022) (H1N1)
22/118	Influenza Virus Infectious NIB-129 (H3N2)
22/268	Influenza Virus Infectious SAN-015 (A/Lyon/820/2021) (H1N1)
21/382	Influenza Virus Infectious X-367A (H3N2)
21/384	Influenza Virus Infectious X-369A (H3N2)
Product Code	Microbiome
22/212	NIBSC Reference Reagent for DNA extractions of gut microbiome samples (WC-Gut-RR)
20/302	WHO International Reference Reagent for GUT Microbiome analysis by NGS (Gut-Mix RR)
20/304	WHO Reference Reagent for GUT Microbiome analysis by NGS (DNA-Gut-HiLo)
Product Code	Monoclonal antibodies
22/242	Anti-pneumococcal serotype 11A monoclonal antibody
22/256	Anti-pneumococcal serotype 15A/B monoclonal antibody
22/244	Anti-pneumococcal serotype 15B monoclonal antibody
22/258	Anti-pneumococcal serotype 16F monoclonal antibody
22/246	Anti-pneumococcal serotype 17F monoclonal antibody
22/260	Anti-pneumococcal serotype 19F monoclonal antibody
22/236	Anti-pneumococcal serotype 2 monoclonal antibody
22/248	Anti-pneumococcal serotype 20 monoclonal antibody
22/262	Anti-pneumococcal serotype 23F monoclonal antibody
22/264	Anti-pneumococcal serotype 24F monoclonal antibody
22/250	Anti-pneumococcal serotype 33F monoclonal antibody
22/266	Anti-pneumococcal serotype 35B monoclonal antibody
22/238	Anti-pneumococcal serotype 4 monoclonal antibody
22/240	Anti-pneumococcal serotype 6B monoclonal antibody
22/254	Anti-pneumococcal serotype 6C monoclonal antibody
32-1	Filamentous Haemagglutinin monoclonal antibody, clone 32-1
FHADETOX/6	Filamentous Haemagglutinin monoclonal antibody, clone FHADETOX/6
1-7	Fimbrae monoclonal antibody, clone 1-7
G10F8C3	Fimbrae monoclonal antibody, clone G10F8C3
3-5	Pertactin Monoclonal antibody, Clone 3-5
69K/16	Pertactin monoclonal antibody, clone 69K/16
629 e1	Pertussis toxoid monoclonal antibody, clone 629E1
PS21C2.2.1	Pertussis toxoid monoclonal antibody, clone PS21C2.2.1
21/230	1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test
8E1-1H1.2.1	Tetanus toxoid monoclonal antibody, clone 8E1-1H1.2.1
TT010	Tetanus toxoid monoclonal antibody, clone TT010
Product Code	COVID-19
22/B896-01	Anti-SARS-CoV-2 Verification Panel for Serology Assays
101062	HEK293T-ACE2-30F-PLP2
101037	Inactivated (acetic acid + heat) SARS-Cov-2 Gamma (P.1 lineage)
101047	Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage)
21/338	1st International Standard for antibodies to SARS-CoV-2 variants of concern
20/270	SARS-CoV-2 Ag QC
20/270-002	SARS-CoV-2 Ag QC
21/368	SARS-Cov-2 Antigen 1st WHO International Standard
101055	SARS-CoV-2 Omicron (BA.2)
101054	SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022
Product Code	Serology diagnostics
03/104-022	HTLV-1 (antibody) Monitor Sample
20/168-002	Monitor Sample for Anti HTLV-II
20/168-003	Monitor Sample for Anti HTLV-II
21/B889-01	QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1
21/B882-01	QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
22/B891-01	QCRTOXOIgMQC1 IgM Anti-Toxoplasma QC1